Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis
文献类型:期刊论文
作者 | Zhang, Rong2,3; Zhang, Zijia2,3; Wu, Wenyong1,2,3; Shi, Jingying2,3; Berk, Entezar2,3,4; Li, Wei2,3; Deng, Yanping2,3; Wang, Zhaojun2,3; Hou, Jinjun2,3![]() |
刊名 | METABOLOMICS
![]() |
出版日期 | 2023-01-16 |
卷号 | 19期号:2页码:13 |
关键词 | Bufadienolides Prostate cancer Lipidomics Transcriptomics ELOVL6 PLD1 |
ISSN号 | 1573-3882 |
DOI | 10.1007/s11306-022-01968-7 |
通讯作者 | Lei, Min(mlei@simm.ac.cn) ; Wu, Wanying(wanyingwu@simm.ac.cn) |
英文摘要 | IntroductionLipid metabolism participates in various biological processes such as proliferation, apoptosis, migration, invasion, and maintenance of membrane homeostasis of prostate tumor cells. Bufadienolides, the active ingredients of Chansu, show a robust anti-proliferative effect against prostate cancer cells in vitro, but whether bufadienolides could regulate the lipid metabolism in prostate cancer has not been evaluated.ObjectivesOur study explored the regulatory effects of bufadienolides on lipid metabolism in human prostate carcinoma cells (PC-3).MethodsUntargeted lipidomics and transcriptomics were combined to study the effect of different bufadienolides interventions on lipid and gene changes of PC-3 cells. The key genes related to lipid metabolism and prostate cancer development were verified by qPCR and western blotting.ResultsLipidomic analysis showed that the active bufadienolides significantly downregulated the content of long-chain lipids of PC-3 cells. Based on transcriptomic and qPCR analyses, many genes related to lipid metabolism were significantly regulated by active bufadienolides, such as ELOVL6, CYP2E1, GAL3ST1, CERS1, PLA2G10, PLD1, SPTLC3, and GPX2. Bioinformatics analysis of the Cancer Genome Atlas database and literature retrieval showed that elongation of very long-chain fatty acids protein 6 (ELOVL6) and phospholipase D1 (PLD1) might be important regulatory genes. Western blot analysis revealed that active bufadienolides could downregulate PLD1 protein levels which might promote anti-prostate cancer effect.ConclusionsAll these findings support that bufadienolides might induce lipid metabolic remodeling by regulating long-chain lipids synthesis and phospholipid hydrolysis to achieve an anti-prostate cancer effect, and PLD1 would probably be the key protein. |
WOS关键词 | TANDEM MASS-SPECTROMETRY ; CANCER ; GLYCEROPHOSPHOLIPIDS ; IDENTIFICATION ; PROLIFERATION ; SPHINGOMYELIN ; EXPRESSION ; DATABASE |
WOS研究方向 | Endocrinology & Metabolism |
语种 | 英语 |
WOS记录号 | WOS:000913643500001 |
出版者 | SPRINGER |
源URL | [http://119.78.100.183/handle/2S10ELR8/303699] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Lei, Min; Wu, Wanying |
作者单位 | 1.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210029, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Natl Engn Ctr TCM Standardizat Technol, Shanghai 201203, Peoples R China 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 4.Capital Med Univ, Sch Tradit Chinese Med, Beijing Key Lab TCM Collateral Dis Theory Res, Beijing 100069, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Rong,Zhang, Zijia,Wu, Wenyong,et al. Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis[J]. METABOLOMICS,2023,19(2):13. |
APA | Zhang, Rong.,Zhang, Zijia.,Wu, Wenyong.,Shi, Jingying.,Berk, Entezar.,...&Wu, Wanying.(2023).Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis.METABOLOMICS,19(2),13. |
MLA | Zhang, Rong,et al."Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis".METABOLOMICS 19.2(2023):13. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。